Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Sytrinol™, the proprietary cardiovascular wellness compound from SourceOne Global Partners, will be the subject of a phase III clinical trial. This study is designed as a double-blind, crossover, randomized trial of 120 moderately hypercholesterolemic men and women who are divided into two groups of 60 each. They will consume either a dosage of 150 mg Sytrinol or placebo twice daily for 12 weeks.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters